Myriad Genetics' GAAP loss for 3 months of 2022 was $20.5 million, down 48.1% from $39.5 million in the previous year. Revenue decreased 4.7% to $164.9 million from $173.1 million a year earlier.
Myriad Genetics' GAAP loss for 3 months of 2022 was $20.5 million, down 48.1% from $39.5 million in the previous year. Revenue decreased 4.7% to $164.9 million from $173.1 million a year earlier. 
myriad.com
English (US) 